247 results
Page 7 of 13
8-K
EX-99.1
aiknrwpuzz02mrcew
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
fxdzyndrsv y38hygzcj
8 Aug 11
Ligand Pharmaceuticals Announces Second Quarter Results
12:00am
8-K
EX-99.1
cuny9ksx6 bmzjv1ht
26 Jul 11
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta® PIII
12:00am
8-K
EX-99.1
fip6kbkr6395 owphttu
22 Jun 11
Product has Potential to Offer Important Advantages Over Current IV Melphalan
12:00am
8-K
EX-99.1
njq5bcorxvc bp
20 Jun 11
Rob McKay, Sr. Dir. Business Development
12:00am
8-K
EX-99.1
ilymrle3l
10 May 11
Ligand Pharmaceuticals Reports First Quarter Results
12:00am
8-K
vhpwasq 8qng
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
oe7e85vm
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
y94740s43i
15 Feb 11
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12:00am
8-K
EX-99.1
ku2liid
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am
8-K
EX-99.1
8bvrirod df8z0y
31 Jan 11
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
12:00am
8-K
EX-99.1
dxp4tye66smr0
7 Oct 10
Regulation FD Disclosure
12:00am
8-K
EX-10.1
5vckqtrfdrr3q2y7
3 May 10
Entry into a Material Definitive Agreement
12:00am